Huntsworth traded well through November and expects to at least reach the $30.6M profit consensus for 2017, according to its financial update released today.
Strong growth from Huntsworth Health, especially from its Evoke and Apothecom units, which generate more than 65 percent of healthcare revenues and profits, drove overall corporate performance.
The firm also received a boost from The Creative Engagement Group digital business, which was acquired in July, as CEO Paul Taaffe completed TCEG's integration into Huntsworth. TCEG is now busy lining up new business ventures with Huntsworth operating units, which include Red, Grayling and Citigate Dewe Rogerson.
Huntsworth “is confident about future trading and expects continued good growth prospects in its healthcare businesses," according to the report.The company will announce full-year 2017 financials on March 8.